White House pharmacy under the microscope
This week's D.C. Diagnosis newsletter digs into troubles at the White House's pharmacy and the way Biden might benefit from pharma suing over Medicare's new power to negotiate drug prices.…
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.
Inside the White House pharmacy
The little-known White House pharmacy is under a government watchdog’s microscope, and the picture isn’t pretty. In a searing new report, the inspector general recounts a doctor asking a pharmacy staffer to “hook up” someone with a controlled substance as a “parting gift.” Over-the-counter medicines were available in open bins, while some controlled medicines were dispensed without verifying patients’ identities, Brittany Trang reports.
What's Your Reaction?
